Acupuncture for Primary Sjögren Syndrome

Efficacy and Safety of Acupuncture for Primary Sjögren Syndrome

The purpose of this study is to determine whether acupuncture is effective and safe in the treatment of Primary Sjögren Syndrome.

Study Overview

Detailed Description

This randomized, double-blinded, sham acupuncture controlled trial is aimed to assess the effectiveness and safety of acupuncture in the treatment of Primary Sjögren Syndrome.The eligible participants will be randomly allocated to receive acupuncture or sham acupuncture for 8 weeks.

Assuming a two-sided alpha of 0.05, power of 85%, and a 20% drop-out, a sample sized of 30 would be needed for each group. The statistical analysis will be based on the intention-to-treat principle. Continuous variables will be compared by Student t test or Mann-Whitney U test; categorical variables will be analyzed by chi-square test, Fisher's exact test or Kruskal-Wallis H test as appropriate. For comparison between two time points, paired t-test or Wilcoxon signed rank test will be used as appropriate. A statistically significant difference was set at P<0.05.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Beijing, China, 100053
        • Guang'anmen Hospital, China Academy of Chinese Medical Sciences
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • To fulfill the American-European Consensus Group Criteria for primary Sjögren syndrome.
  • With the symptoms of primary Sjögren syndrome less than 5 years.

Exclusion Criteria:

  • With an acupuncture contraindication (allergy to metals, skin lesions on relative acupoints, etc.)
  • Taking or taken medicine for primary Sjögren syndrome within last 4 weeks before the enrollment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Acupuncture group
Participants will receive acupuncture for 8 weeks. In particular, acupuncture will be performed three times a week in earlier 4 weeks and twice a week in later 4 weeks.
Acupoints include 11 on the head, two on the upper extremities, and two on the lower extremities. Before performing acupuncture, a small pad will be pasted on each acupoint. All the needles will insert the acupoints through these pads. Then, they will be twirled, lifted and thrust three times to elicit the Deqi sensation. Each session will last 30 minutes.
SHAM_COMPARATOR: Sham Acupuncture group
Participants will receive sham acupuncture for 8 weeks. The procedure is the same as the acupuncture arm.
The same acupoints with acupuncture group are selected.A placebo needle with a blunt tip will be used to perform sham acupuncture. They will only insert the pad and no skin penetration. The same procedure with acupuncture group will be performed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The proportion of participants who has a 30% or greater reduction in 2 of 3 items,including the numeric analog scale (NAS) of dryness, fatigue, and pain.
Time Frame: 24 weeks
Subjects will be asked to provide every NAS score based on the average situation over the past 24 hours 13 rather than a point of time. And we will collect NAS scores three times a week in week0-8 (24 times in total) as removal of a variety of factors causing bias, including mental relaxation in weekend, weather changing, or unexpected events life in, etc., each of which may influence the feelings of dryness, fatigue, and pain.
24 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in NAS of each item including dryness, fatigue, and pain.
Time Frame: 24 weeks
Subjects will be asked to provide every NAS score based on the average situation over the past 24 hours 13 rather than a point of time. And we will collect NAS scores three times a week in week0-8 (24 times in total) as removal of a variety of factors causing bias, including mental relaxation in weekend, weather changing, or unexpected events life in, etc., each of which may influence the feelings of dryness, fatigue, and pain.
24 weeks
Change in EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI)
Time Frame: 24 weeks
it will be measured at week0/8/16/24
24 weeks
Change in Medical Outcome Study Short Form 36 Short-Form Health Survey (SF-36)
Time Frame: 24 weeks
it will be measured at week0/8/16/24
24 weeks
Change in Hospital Anxiety and Depression (HAD) scale score
Time Frame: 24 weeks
it will be measured at week0/8/16/24
24 weeks
Change in serum Immunoglobulin G (IgG),immunoglobulin A (IgA), and immunoglobulin M (IgM) levels
Time Frame: 24 weeks
it will be measured at week0/24
24 weeks
Change in image of Salivary glands measured by ultrasound
Time Frame: 24 weeks
it will be measured at week0/24
24 weeks
Change in Schirmer test score and unstimulated salivary flow
Time Frame: 24 weeks
it will be measured at week0/8/16/24
24 weeks
Adverse events
Time Frame: 24 weeks
it will be measured at week0/8/16/24, and be observed, documented, and evaluated in detail.
24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Xinyao Zhou, MD, Guang'anmen hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2016

Primary Completion (ANTICIPATED)

March 1, 2017

Study Completion (ANTICIPATED)

March 1, 2017

Study Registration Dates

First Submitted

February 20, 2016

First Submitted That Met QC Criteria

February 20, 2016

First Posted (ESTIMATE)

February 25, 2016

Study Record Updates

Last Update Posted (ESTIMATE)

February 29, 2016

Last Update Submitted That Met QC Criteria

February 26, 2016

Last Verified

February 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sjogren's Syndrome

Clinical Trials on acupuncture group

3
Subscribe